Hormone-resistant prostate cancer

被引：0
|
作者：
Khoury, S [1 ]
机构：
[1] Hop Pitie, Urol Serv, Paris, France
来源：
PROGRES EN UROLOGIE | 2002年 / 12卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：7 / 18
页数：12
相关论文
共 50 条
  • [31] Docetaxel plus prednisone therapy in patients with hormone-resistant prostate cancer
    Karabacak, Osman Raif
    Yigitbasi, Orhan
    Sertcelik, Nurettin
    Yalcinkaya, Fatih
    [J]. INTERNATIONAL JOURNAL OF UROLOGY, 2010, 17 : A208 - A208
  • [32] WEEKLY LOW-DOSE ADRIAMYCIN IN HORMONE-RESISTANT METASTATIC CANCER OF THE PROSTATE
    FOSSA, SD
    URNES, T
    KAALHUS, O
    [J]. SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY, 1987, 21 (01): : 13 - 16
  • [33] THE PROGNOSTIC-SIGNIFICANCE OF PROSTATE SPECIFIC ANTIGEN IN METASTATIC HORMONE-RESISTANT PROSTATE-CANCER
    FOSSA, SD
    WAEHRE, H
    PAUS, E
    [J]. BRITISH JOURNAL OF CANCER, 1992, 66 (01) : 181 - 184
  • [34] Sphingosine kinase 1 inhibition sensitizes hormone-resistant prostate cancer to docetaxel
    Sauer, Lysann
    Nunes, Joao
    Salunkhe, Vishal
    Skalska, Lenka
    Kohama, Takafumi
    Cuvillier, Olivier
    Waxman, Jonathan
    Pchejetski, Dmitry
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2009, 125 (11) : 2728 - 2736
  • [35] Chemotherapy in early stage of hormone-resistant metastatic prostate cancer: what are the indications?
    Drouin, S. J.
    Roupret, M.
    Wallerand, H.
    Houede, N.
    [J]. PROGRES EN UROLOGIE, 2010, 20 : S192 - S197
  • [36] AMERICAN-STUDIES ON SURAMIN THERAPY IN HORMONE-RESISTANT PROSTATE-CANCER
    ROSEN, P
    BELLDEGRUN, A
    [J]. CANCER SURVEYS, 1995, 23 : 231 - 234
  • [37] Efficacy of Taxotere, Thalidomide, and Prednisolone in Patients with Hormone-Resistant Metastatic Prostate Cancer
    Rezvani, Hamid
    Ghadyani, Shirin Haghighi Mojtaba
    Attarian, Hamid
    [J]. UROLOGY JOURNAL, 2012, 9 (04) : 673 - 677
  • [38] Sphingosine kinase inhibition to sensitize hormone-resistant prostate cancer cells to docetaxel
    Pshezhetskiy, Dmitry
    [J]. FASEB JOURNAL, 2009, 23
  • [39] A phase II study of vinorelbine and estramustine in patients with hormone-resistant prostate cancer
    Galcerán J.C.
    Piulats R.B.
    Martín-Broto J.
    Rey P.M.
    Aligué M.N.
    Santasusana M.D.
    Lanza A.A.
    Molins J.B.
    Colin C.
    Girard A.
    [J]. Clinical and Translational Oncology, 2005, 7 (2) : 66 - 73
  • [40] The radiation response of hormone-resistant prostate cancer induced by long-term hormone therapy
    Wu, Chun-Te
    Chen, Wen-Cheng
    Liao, Shuen-Kuei
    Hsu, Cheng-Lung
    Lee, Kuan-Der
    Chen, Miao-Fen
    [J]. ENDOCRINE-RELATED CANCER, 2007, 14 (03) : 633 - 643
12345